Primary Job Title CEO Primary Organization 
Inthera Bioscience
Location Denmark, South Carolina, United States Regions East Coast, Southern US Gender Male
Facebook View on Facebook LinkedIn View on LinkedIn
Martin Bonde joined Vaccibody in August 2015. He holds a Ph.D. in Immunochemical Techniques and a Master of Science in Chemical Engineering from the Technical University of Denmark as well as a Bachelor of Commerce in International Economy from Copenhagen Business School.
Bonde started his career in Dako AS, followed by Ostemeter AS (CEO),
Torsana Biosensor AS (CEO), Celtor Biosystems Inc (EVP), Combio AS (CEO), Natimmune AS (CEO), Aros Pharma ApS (CEO) and most recently Epitherapeutics Aps now sold to Gilead (CEO).
His experience includes a significant number of transactions within business development, trade sales, mergers & acquisitions as well as management of research and development.
